ClinicalTrials.Veeva

Menu
T

The Medical Research Network | New York, NY

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Rapastinel
Pregabalin
Tanezumab
Esketamine
Dasotraline
BHV-7000
CERC-301
Viloxazine
HYD
Pimavanserin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 60 total trials

A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression

The purpose of this study is to evaluate how well each individual dose of esketamine (56 milligrams \[mg\] and 84 mg) works when compared with placeb...

Enrolling
Depressive Disorder, Treatment-Resistant
Drug: Placebo
Drug: Esketamine 84 mg

The purpose of this study is to assess whether JNJ-64042056 affects the spread and build up of tau (a protein in brain) when compared with placebo, u...

Active, not recruiting
Alzheimer Disease
Drug: JNJ-64042056
Drug: Placebo

This Phase 2 study (protocol number VLS-01-203) will determine the efficacy, safety, and tolerability of short-term treatment with a VLS-01 transmuco...

Enrolling
Treatment Resistant Depression
Drug: VLS-01-BU Placebo
Drug: VLS-01-203 BU

The primary purpose of this study is to evaluate the efficacy of centanafadine once daily (QD) extended-release (XR) capsules in adults with attentio...

Enrolling
Attention-deficit/Hyperactivity Disorder
Emotional Dysregulation
Drug: Centanafadine XR

Trial sponsors

Pfizer logo
Allergan logo
Janssen (J&J Innovative Medicine) logo
Otsuka logo
T
Sumitomo Pharma logo
Acadia Pharmaceuticals logo
Avalo Therapeutics logo
Biohaven logo
E

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems